Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial - Wheeler, CM; Castellsagué, X; Garland, SM (Lancet Oncol, 2012)
et al.